naproxen tablet
INDICATIONS AND USAGE Carefully consider the potential benefits and risks of naproxen tablets and other treatment options before deciding to use naproxen tablets. Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals (see WARNINGS: Gastrointestinal Bleeding, Ulceration, and Perforation) . Naproxen tablets are indicated: For the relief of the signs and symptoms of rheumatoid arthritis For the relief of the signs and symptoms of osteoarthritis For the relief of the signs and symptoms of ankylosing spondylitis For the relief of the signs and symptoms of juvenile arthritis Naproxen tablets are also indicated: For relief of the signs and symptoms of tendonitis For relief of the signs and symptoms of bursitis For relief of the signs and symptoms of acute gout For the management of pain For the management of primary dysmenorrhea
aphena pharma solutions - tennessee, llc
OVAL PINK IG 341
IG 341 OVAL PINK
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED ​
NAPROXEN Tablets, USP: ​250 mg: Light yellow, round, biconvex tablets de-bossed with ‘I’ ​ on the left side of bisect and ‘G’ ​ on the right side of bisect on one side and ‘340’ ​ on the other, supplied in bottles of 100’s count (NDC 76282-340-01) and 500’s count (NDC 76282-340-05).
NAPROXEN Tablets, USP: ​375 mg: Light pink, capsule shaped, biconvex tablets de-bossed with ‘IG’ ​ on one side and ‘341’ ​ on the other, supplied in bottles of 100’s count (NDC 76282-341-01) and 500’s count (NDC 76282-341-05). ​
NAPROXEN Tablets, USP: ​500 mg: Light yellow, capsules shaped, biconvex tablets de-bossed with ‘I’ ​ on the left side of bisect and ‘G’ ​ on the right side of bisect on one side and ‘342’ ​ on the other, supplied in bottles of 100’s count (NDC 76282-342-01) and 500’s count (NDC 76282-342-05). Store at 20° to 25°C (68° to 77°F); [See USP Controlled Room Temperature]. Dispense in tight, light-resistant containers. *All brand names mentioned are registered trademark of their respective owners and are not of Exelan Pharmaceuticals, Inc. Rev: 06/2016
More pills like OVAL IG 341